Composition:
Each TruGlif tablet contains 10 mg of Empagliflozin
Description:
TruGlif tablets contain empagliflozin, an orally active inhibitor of the Sodium-Glucose Co-Transporter 2 (SGLT2).
Indications:
TruGlif is indicated:
• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.
Limitation of Use:
Not for the treatment of type 1 diabetes mellitus and/or diabetic ketoacidosis.
Dosage:
The recommended dose of Truglif is 10 mg once daily in the morning, taken with or without food.
DISCLAIMER
Super Health’s intention is to make sure that its consumers get information that is accurate, reviewed by an expert, and error-free. However, the information mentioned here should not be used as a replacement for the advice of a qualified physician. The information given here is for informational purposes only, and may not cover all possible precautions, side effects, contraindications, or drug interactions. Consult your doctor and discuss your queries related to any medicine or disease.
Find us on map
Reviews
There are no reviews yet